Removal by human apurinic/apyrimidinic endonuclease 1 (Ape 1) and Escherichia coli exonuclease III of 3′-phosphoglycolates from DNA treated with neocarzinostatin, calicheamicin, and γ-radiation
- 1 March 1999
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 57 (5) , 531-538
- https://doi.org/10.1016/s0006-2952(98)00327-x
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- DNA damage and mutagenesis by radiomimetic DNA-cleaving agents: bleomycin, neocarzinostatin and other enediynesMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1996
- REPAIR OF OXIDATIVE DAMAGE TO DNA: Enzymology and BiologyAnnual Review of Biochemistry, 1994
- The Complexity of DNA Damage: Relevance to Biological ConsequencesInternational Journal of Radiation Biology, 1994
- Exclusive production of bistranded DNA damage by calicheamicinBiochemistry, 1993
- Free-radical mechanisms involved in the formation of sequence-dependent bistranded DNA lesions by the antitumor antibiotics bleomycin, neocarzinostatin, and calicheamicinChemical Research in Toxicology, 1992
- Neocarzinostatin-mediated DNA damage in a model AGT.cntdot.ACT site: mechanistic studies of thiol-sensitive partitioning of C4' DNA damage productsBiochemistry, 1992
- Human HeLa cell enzymes that remove phosphoglycolate 3′-end groups from DNANucleic Acids Research, 1992
- Two distinct human DNA diesterases that hydrolyze 3′-blocking deoxyribose fragments from oxidized DNANucleic Acids Research, 1991
- Calicheamicin γ 1 I : an Antitumor Antibiotic That Cleaves Double-Stranded DNA Site SpecificallyScience, 1988
- The relative importance ofEscherichia coliexonuclease III and endonuclease IV for the hydrolysis of 3′-phosphoglycolate ends in polydeoxynucleotidesNucleic Acids Research, 1988